Additionally, neoantigen-specific robust T cell responses were identified in most HCC patients, while cellular profiling confirmed the activation, proliferation, and cytolytic activity of vaccine-specific CD4+ and CD8+ effector T cells [94]. Here, CD8A is linked to hepatocellular carcinoma.